Picture of Akoya Biosciences logo

AKYA — Akoya Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Brief: Akoya Reports Third Quarter Results, Raises Full Year 2022 Revenue Guidance

Nov 7 (Reuters) - Akoya Biosciences Inc  AKYA.O :
    * AKOYA REPORTS RECORD REVENUE WITH 40% YOY GROWTH IN THE
THIRD
QUARTER AND RAISES FULL YEAR 2022 REVENUE GUIDANCE
    * Q3 REVENUE ROSE 40 PERCENT TO $18.9 MILLION
    * RAISING ITS FULL YEAR 2022 REVENUE GUIDANCE RANGE TO $73
MILLION
-$75 MILLION
    * QTRLY NET LOSS PER SHARE $0.47
    * Q3 EARNINGS PER SHARE VIEW $-0.44, REVENUE VIEW $17.7
MILLION --
REFINITIV IBES DATA
    * FY2022 REVENUE VIEW $72.3 MILLION -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX9MJdrk 
Further company coverage:  AKYA.O 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Akoya Biosciences

See all news